Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
LILixte Biotechnology Holdings, Inc. logo

Lixte Biotechnology Holdings, Inc. (LIXT)

NASDAQ Capital Market · Currency in USD
$7.21 ▼ -0.46 (-6.00%)
At close: Jul 2, 4:00 PM ET. Market closed.
$7.58 ▲ +0.37 (+5.13%)
After hours: Jul 2, 7:43 PM ET

Summary

Previous Close
$7.67
Open
$7.81
Day's Range
$7.00 – $7.95
52 Week Range
$2.02 – $8.38
Volume
615,057
Avg. Volume
238,595
Market Cap
$89.11M
Beta (5Y Monthly)
1.25
PE Ratio (TTM)
--
EPS (TTM)
-$0.64
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Lixte Biotechnology Holdings, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
3
CEO
Geordan G. Pursglove
Website
lixte.com

Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespread diseases, then designs innovative compounds to act upon these targets. The company's primary focus lies in protein phosphatase inhibitors, which are being investigated for use both independently and in combination with cytotoxic agents, radiation therapy, and immune checkpoint blockers.

Earnings

DateEst.Actual
May 14, 2026–-$0.18
Mar 31, 2026–-$0.33
Nov 12, 2025–-$0.33
Aug 7, 2025–-$0.29
May 12, 2025–-$0.29
Mar 24, 2025–-$0.27

Get free alerts on LIXT and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.